Relaxation Response Training to Treat Hypertension
Relaxation Response Training to Treat Hypertension: Effects on Blood Pressure, Biomarkers, and Endothelial Function
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
General Inclusion Criteria:
- Healthy men and women
- Hypertension (stage 1)
- 18-70 years old
General Exclusion Criteria
- No asthma or nasal allergies
- Non-smokers
- If on anti-hypertensive medication willing to discontinue
- Cannot currently practice Tai Chi, meditation, or yoga regularly
- Current use of the following medications: phosphodiesterase type 5 inhibitors, long-acting nitrates, systemic corticosteroids, anti-inflammatories, immunosuppressive or cytotoxic therapies (currently or within the last 12 months), anabolic steroids, and antidepressants.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: This is a single arm study
Relaxation Response training will be given to all participants
|
The Relaxation Response is a type of relaxation.
The goal of the Relaxation Response is to consciously elicit a reaction opposite in direction to the stress response.
Other Names:
Relaxation Response is a type of relaxation.
This is a technique that elicits a state that is opposite to the stress response.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Endothelial Function
Time Frame: Eight weeks of Relaxation Response Training
|
Eight weeks of Relaxation Response Training
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Blood Pressure
Time Frame: Eight Weeks of Relaxation Response Training
|
Eight Weeks of Relaxation Response Training
|
|
Genomic Expression
Time Frame: Eight Weeks of Relaxation Response Training
|
Eight Weeks of Relaxation Response Training
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Herbert Benson, MD, Massachusetts General Hospital
- Study Director: Gregory Fricchione, MD, Massachusetts General Hospital
- Principal Investigator: Jeffrey Huffman, MD, Massachusetts General Hospital
- Study Director: Randall Zusman, MD, Massachusetts General Hospital
- Study Director: Mark A Creager, MD, Brigham and Women's Hospital
- Study Director: John W Denninger, MD, Massachusetts General Hospital
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2008P002244
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.